GlassScriptPhysician profile
Joseph Mekhail
NPI 1023540846
$3,157.84
in general payments reported to CMS, 2019-2025
20 companies · $890 in 2025
The $890 reported for 2025 was more than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $459 · 2022: $750 · 2023: $414 · 2024: $645 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,948.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $998.37 | 2021-2025 | Clareon Panoptix Pro, Clareon, Eysuvis |
| Bausch & Lomb Americas INC. | $393.29 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Glaukos Corporation | $288.76 | 2022-2025 | Photrexa Viscous and Photrexa |
| Sun Pharmaceutical Industries INC. | $230.01 | 2022-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $189.50 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $154.36 | 2021-2025 | Tecnis Iol, Catalys System, Tecnis Simplicity |
| Rxsight INC | $136.70 | 2022-2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Amgen INC. | $127.47 | 2024-2025 | Tepezza |
| Kala Pharmaceuticals, INC. | $124.99 | 2022 | |
| Oyster Point Pharma, INC. | $121.75 | 2022-2023 | Tyrvaya |
| Sight Sciences, INC. | $106.62 | 2021-2024 | Omni Surgical System, Sion Surgical Instrument |
| Biotissue Holdings INC. | $71.66 | 2024-2025 | |
| Dompe US, INC. | $56.72 | 2022-2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.61 | 2021 | |
| Thea Pharma INC. | $23.81 | 2024 | Iyuzeh |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $21.69 | 2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Harrow Eye, LLC | $20.49 | 2025 | |
| Rayner Intraocular Lenses Limited | $17.37 | 2024 | Rayone Spheric, Rayone Emv, Omidria |
| Novartis Pharmaceuticals Corporation | $16.76 | 2023 | |
| Horizon Therapeutics Plc | $13.91 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mekhail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.